Estela Rodriguez/X
May 13, 2025, 15:16
Estela Rodriguez: When more is not necessarily better – SBRT vs conventional RT for Painful Bone Metastases
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, shared a post on X:
“When more is not necessarily better: SBRT vs conventional RT for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial
(N=126) SBRT failed to demonstrate statistically significant improvement in CR rates after 1 month.”
Title: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial
Authors: Carole Mercier, Charlotte Billiet, Piet Ost, Katrien Vandecasteele, Geert De Kerf, Michaël Claessens, Steven Van Laere, Peter Vermeulen, Luc Dirix, Yolande Lievens, Dirk Verellen, Piet Dirix
Read the Full Article in Journal of Clinical Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 3, 2025, 08:06
Jun 3, 2025, 08:01
Jun 3, 2025, 07:55
Jun 3, 2025, 07:47
Jun 3, 2025, 07:43
Jun 3, 2025, 07:37
Jun 3, 2025, 07:30